| Literature DB >> 32363247 |
Sara Samiee1, Farimah Hadjilooei1, Mahboobeh Alamolhoda2, Shahram Akhlaghpoor3.
Abstract
On February 19, 2020, the first case of a patient infected with Coronavirus Disease-2019 (COVID-19) was announced in Iran. The number of infected patients increased rapidly, and all health care centers faced an extremely challenging situation in Iran. The centers had to adopt new regulations and approaches to keep their patients and staff safe while providing service to society. Patients diagnosed with a malignancy are at a higher risk for infection with COVID-19 with a poorer prognosis. The Pardis Noor Radiology-Oncology center is a private center in Tehran composed of different departments, including radiation therapy and chemotherapy. Soon after the outbreak, we changed our rules and regulations for patients and staff. This is a report from a private radiology-oncology center in Tehran during the COVID-19 outbreak.Entities:
Year: 2020 PMID: 32363247 PMCID: PMC7195356 DOI: 10.1016/j.adro.2020.04.005
Source DB: PubMed Journal: Adv Radiat Oncol ISSN: 2452-1094
Figure 1Total Coronavirus infections (23,049) in Iran as of March 23, 2020 (deaths = 1812, recovered = 8376). Printed with permission from https://behdasht.gov.ir/.
Names, locations, and departments of each branch of Pardis Noor Radiology-Oncology Center
| Branch name | Location | Area of the city served | Departments |
|---|---|---|---|
| Pardis Noor Radiology | Northwest | West | Diagnostic and interventional radiology, nuclear medicine |
| Pardis Noor Salamat | Center | Central area and South | Diagnostic and interventional radiology, medical laboratory |
| Pardis Noor Niloo | North | North and East | Diagnostic and interventional radiology, radiation therapy, chemotherapy |
Figure 2Locations of the 3 branches of Pardis Noor Radiation-Oncology Centre.
Departments of Pardis Noor Niloo (North Eastern Branch of Pardis Noor Radiology-Oncology Center)
| Radiation therapy ward | Outpatient clinic | Treatment unit | Physics and dosimetry group | |
|---|---|---|---|---|
| Chemotherapy ward | Outpatient Clinic | Transfusion unit | ||
| Diagnostic radiology | Magnetic resonance imaging | Computed tomography scan | Ultrasound | Conventional radiology |
| Interventional radiology |
Number of visits at Pardis Noor Niloo Radiology-Oncology center (Northeast branch) within weeks –1, +1, and +3
| Week | Total patient visits at the center | Chest CT scan | All CT scans except chest | MRI | Interventional radiology | Bone mineral density | Ultrasound | Mammogram | Conventional radiology | Radiation treatments |
|---|---|---|---|---|---|---|---|---|---|---|
| –1 | 499 | 6 | 91 | 127 | 10 | 9 | 121 | 25 | 13 | 103 |
| +1 | 394 | 27 | 76 | 71 | 13 | 4 | 60 | 12 | 33 | 98 |
| +3 | 191 | 18 | 48 | 18 | 9 | 1 | 23 | 3 | 6 | 65 |
CT = computed tomography; MRI = magnetic resonance imaging; week –1 = week before the outbreak; week +1 = first week after the outbreak; week +3 = third week after the outbreak
The center rules were implemented at the end of the first week. The number of patients visiting this center in week +3 is reduced by 50% compared with week –1.
Figure 3Flowchart of decision-making after screening patients, visitors, and staff at the entrance.
Figure 4Pardis Noor Radiology Oncology Center through Covid-19 outbreak.
Systematic approach to decision making
| Goals of treatment | Types of treatment | Examples of treatment | Decision making for radiation therapy |
|---|---|---|---|
| Curative | Radical | Head and neck cancer, cervical cancer | |
| Adjuvant | Breast cancer, sarcoma, head and neck cancer, moderate- and high-risk prostate cancer, endometrial cancer | ||
| Neoadjuvant | Rectal cancer, sarcoma | ||
| Palliative | Emergency | Cord compression, superior vena cava obstruction, life-threatening bleeding | |
| Pain control | Bone metastasis, multiple brain metastasis |
Note: Stereotactic ablative body radiation or stereotactic radiosurgery for brain lesions is not available in Iran.
Do not defer treatment unless a reasonable alternative exists (eg, start hormone therapy for intermediate- and high-risk prostate cancer and defer radiation treatment for a couple of weeks). If decision is made to start radiation therapy (eg, nasopharyngeal cancer), extensive education on hand hygiene and physical distancing is given directly by the radiation oncologist. All patients have access to hotline to ask questions and report symptoms. Whenever possible, hypofractionated regimen is used.
Categorize evidence behind the indication of radiation therapy and absolute benefit of the treatment. Categorize if there is survival benefit from radiation therapy versus local control benefit (eg, boost in breast radiation therapy can be omitted). Assess whether alternative exists to defer or replace radiation therapy. Prioritize by age and other comorbidities of the patient. Radiation treatment can be deferred for some time (eg, radiation treatment might be canceled for elderly patients with early stage breast cancer). Some cases will be deferred or cancelled in this category.
Defer the treatment and try to use alternative options, such as medical treatment for pain control or use steroidal drugs for multiple brain metastasis.